IHS Chemical Week

Regions :: North America :: U.S.

Bayer to divest interventional device business to Boston Scientific for $415 million

5:47 AM MDT | May 15, 2014 | Deepti Ramesh

Bayer HealthCare, a subgroup of Bayer, has entered into a definitive agreement to sell its interventional device business to medical devices company Boston Scientific (Natick, MA), for $415 million. Bayer’s interventional business, which is based near Minneapolis, generated sales of about $120 million in 2013 and employs about 350 people. The sale will include the AngioJet Ultra Thrombectomy System and the Jetstream Atherectomy System, as well as the Fetch2 Aspiration Catheter used in cardiology, radiology, and peripheral vascular procedures. The...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa